Marksans Pharma Limited has informed the Exchange about Schedule of conference call for analysts and investors on Wednesday, May 27, 2026 at 04:30 PM (IST) to discuss the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Marksans Pharma has scheduled an earnings conference call for Wednesday, May 27, 2026 at 04:30 PM IST to discuss the audited standalone and consolidated financial results for Q4 and full year FY26 (ended March 31, 2026). The call will feature company founder and CMD Mr. Mark Saldanha and CFO Mr. Jitendra Sharma. DAM Capital Advisors is coordinating the call with dial-in details provided for global access. A presentation, audio recording, and transcript will be made available on the company's website post-call. This filing is made under SEBI LODR Regulation 30 as a routine investor relations disclosure.
This is a standard pre-results announcement. No material information is disclosed in the filing itself — actual earnings discussion will happen during the call. Investors can note the date to participate or access recordings afterward.